Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Stroke

Free Subscription Articles published in JAMA Neurol Retrieve available abstracts of 123 articles: HTML format

Single Articles

May 2025
1. PACZYNSKI M, Hofmann A, Posey Z, Gregersen M, et al
   Lecanemab Treatment in a Specialty Memory Clinic.
   JAMA Neurol. 2025 May 12:e251232. doi: 10.1001/jamaneurol.2025.1232.
   PubMed     Abstract available
   
   
   
2. OLTHUIS SGH, Pinckaers FME, Robbe MMQ, de Ridder IR, et al
   CT Perfusion Imaging After Selection for Late-Window Endovascular Stroke Treatment: Secondary Analysis of the MR CLEAN-LATE Randomized Trial.
   JAMA Neurol. 2025 May 5:e250716. doi: 10.1001/jamaneurol.2025.0716.
   PubMed     Abstract available
   
   
   April 2025
3. BUTCHER KS, Buck B, Dowlatshahi D, Gioia LC, et al
   Acute Blood Pressure Lowering and Risk of Ischemic Lesions on MRI After Intracerebral Hemorrhage.
   JAMA Neurol. 2025 Apr 21:e250586. doi: 10.1001/jamaneurol.2025.0586.
   PubMed     Abstract available
   
   
   
4. ZAWAR I, Quigg M, Johnson EL, Ghosal S, et al
   Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment.
   JAMA Neurol. 2025 Apr 14:e250552. doi: 10.1001/jamaneurol.2025.0552.
   PubMed     Abstract available
   
   
   
5. VERBURGT E, Fellah L, Ekker MS, Schellekens MMI, et al
   Risk of Poststroke Epilepsy Among Young Adults With Ischemic Stroke or Intracerebral Hemorrhage.
   JAMA Neurol. 2025 Apr 14:e250465. doi: 10.1001/jamaneurol.2025.0465.
   PubMed     Abstract available
   
   
   
6. YANG M, Sun H, Li L, Wu Q, et al
   Use of a Robot-Assisted Thrombectomy System in Acute Ischemic Stroke.
   JAMA Neurol. 2025 Apr 7:e250418. doi: 10.1001/jamaneurol.2025.0418.
   PubMed    
   
   
   March 2025
7. WARACH SJ, Davis LA, Lawrence P, Gajewski B, et al
   Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.
   JAMA Neurol. 2025 Mar 31:e250285. doi: 10.1001/jamaneurol.2025.0285.
   PubMed     Abstract available
   
   
   
8. BOERSMA LVA, Werring DJ, Seiffge DJ
   Immortal Time Bias and Nonlinear Stroke Recurrence Risk-Reply.
   JAMA Neurol. 2025 Mar 31. doi: 10.1001/jamaneurol.2025.0392.
   PubMed    
   
   
   
9. SHEFNER JM, Cudkowicz ME, Genge A, Hardiman O, et al
   Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.
   JAMA Neurol. 2025 Mar 24:e250241. doi: 10.1001/jamaneurol.2025.0241.
   PubMed     Abstract available
   
   
   
10. VAILLANCOURT DE, Barmpoutis A, Wu SS, DeSimone JC, et al
    Automated Imaging Differentiation for Parkinsonism.
    JAMA Neurol. 2025 Mar 17:e250112. doi: 10.1001/jamaneurol.2025.0112.
    PubMed     Abstract available
    
    
    
11. GOELDLIN MB, Fandler-Hofler S, Pezzini A, Manikantan A, et al
    Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage.
    JAMA Neurol. 2025 Mar 3:e250026. doi: 10.1001/jamaneurol.2025.0026.
    PubMed     Abstract available
    
    
    February 2025
12. RIPART M, Spitzer H, Williams LZJ, Walger L, et al
    Detection of Epileptogenic Focal Cortical Dysplasia Using Graph Neural Networks: A MELD Study.
    JAMA Neurol. 2025 Feb 24:e245406. doi: 10.1001/jamaneurol.2024.5406.
    PubMed     Abstract available
    
    
    
13. YUN J, Shin D, Lee EH, Kim JP, et al
    Temporal Dynamics and Biological Variability of Alzheimer Biomarkers.
    JAMA Neurol. 2025 Feb 17:e245263. doi: 10.1001/jamaneurol.2024.5263.
    PubMed     Abstract available
    
    
    
14. ANDREWS J, Paganoni S, Macklin EA, Chibnik LB, et al
    Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
    JAMA Neurol. 2025 Feb 17:e245249. doi: 10.1001/jamaneurol.2024.5249.
    PubMed     Abstract available
    
    
    
15. DEL BENE VA, Howard G, Gropen TI, Lyerly MJ, et al
    Cognitive Decline After First-Time Transient Ischemic Attack.
    JAMA Neurol. 2025 Feb 10:e245082. doi: 10.1001/jamaneurol.2024.5082.
    PubMed     Abstract available
    
    
    
16. VANDEVREDE L, Cho H, Sanderson-Cimino M, Wekselman F, et al
    Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.
    JAMA Neurol. 2025 Feb 10:e245017. doi: 10.1001/jamaneurol.2024.5017.
    PubMed     Abstract available
    
    
    
17. HILDERLEY AJ, Dunbar M, Andersen J, Fehlings D, et al
    Neuromodulation for Children With Hemiparesis and Perinatal Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2025 Feb 3:e244898. doi: 10.1001/jamaneurol.2024.4898.
    PubMed     Abstract available
    
    
    
18. LAU WK, Fehnel CR, Macchi ZA, Mehta AK, et al
    Research Priorities in Neuropalliative Care: A Consensus Statement From the International Neuropalliative Care Society.
    JAMA Neurol. 2025 Feb 3. doi: 10.1001/jamaneurol.2024.4932.
    PubMed     Abstract available
    
    
    
19. BOUILLE F, De Malherbe M, Pico F
    Ischemic Stroke Due to Compression of a Wandering Internal Carotid Artery by the Hyoid Bone.
    JAMA Neurol. 2025 Feb 3. doi: 10.1001/jamaneurol.2024.5028.
    PubMed    
    
    
    January 2025
20. LANSBERG MG, Wintermark M, Chen H, Howard G, et al
    Apixaban to Prevent Covert Infarcts After Cryptogenic Stroke in Patients With Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial.
    JAMA Neurol. 2025 Jan 27:e244838. doi: 10.1001/jamaneurol.2024.4838.
    PubMed     Abstract available
    
    
    
21. XIONG Y, Meng X, Jin A, Campbell BCV, et al
    Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke: The PUMICE Randomized Clinical Trial.
    JAMA Neurol. 2025 Jan 21. doi: 10.1001/jamaneurol.2024.4688.
    PubMed     Abstract available
    
    
    
22. ZHU J, Kim KR, Yu H, Gupta A, et al
    Acute Ischemic Stroke Care Quality Improvement.
    JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4604.
    PubMed    
    
    
    
23. YANG S, Orlova Y, Park H, Smith SM, et al
    Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine.
    JAMA Neurol. 2025 Jan 6. doi: 10.1001/jamaneurol.2024.4537.
    PubMed     Abstract available
    
    
    December 2024
24. HANSEN D, den Hartog SJ, van Leeuwen N, Boiten J, et al
    Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke: A Cluster Randomized Clinical Trial.
    JAMA Neurol. 2024 Dec 16. doi: 10.1001/jamaneurol.2024.4304.
    PubMed     Abstract available
    
    
    November 2024
25. GRAVESTEIJN G, Rutten JW, Cerfontaine MN, Hack RJ, et al
    Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL.
    JAMA Neurol. 2024 Nov 29. doi: 10.1001/jamaneurol.2024.4487.
    PubMed     Abstract available
    
    
    
26. MEADOR KJ, Cohen MJ, Loring DW, Matthews AG, et al
    Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical Trial.
    JAMA Neurol. 2024 Nov 25:e243982. doi: 10.1001/jamaneurol.2024.3982.
    PubMed     Abstract available
    
    
    
27. KWON CS, Rafati A, Ottman R, Christensen J, et al
    Psychiatric Comorbidities in Persons With Epilepsy Compared With Persons Without Epilepsy: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2024 Nov 25:e243976. doi: 10.1001/jamaneurol.2024.3976.
    PubMed     Abstract available
    
    
    
28. TSAI CC, Hu C, Ding J, Bui E, et al
    Trends in Gender, Racial, and Ethnic Representation Among US Neurology Faculty.
    JAMA Neurol. 2024 Nov 18:e243909. doi: 10.1001/jamaneurol.2024.3909.
    PubMed    
    
    
    
29. AYTON S, Barton D, Brew B, Brodtmann A, et al
    Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Nov 4:e243733. doi: 10.1001/jamaneurol.2024.3733.
    PubMed     Abstract available
    
    
    
30. LI J, Shlobin NA, Thijs RD, Sylvestre MP, et al
    Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy in the Canadian Longitudinal Study on Aging.
    JAMA Neurol. 2024;81:1178-1186.
    PubMed     Abstract available
    
    
    October 2024
31. MAC GRORY B, Sun JL, Alhanti B, Lusk J, et al
    Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis.
    JAMA Neurol. 2024 Oct 28. doi: 10.1001/jamaneurol.2024.3659.
    PubMed     Abstract available
    
    
    
32. NAVI BB, Khatri P
    Mobile Stroke Units-Time for Legislation and Renumeration.
    JAMA Neurol. 2024 Oct 28. doi: 10.1001/jamaneurol.2024.3627.
    PubMed    
    
    
    
33. LINDGREN E, Shu L, Simaan N, Krzywicka K, et al
    Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis.
    JAMA Neurol. 2024 Oct 21. doi: 10.1001/jamaneurol.2024.3481.
    PubMed     Abstract available
    
    
    
34. KHAN F, Hill MD
    Sex Differences in Case-Fatality Rates of Stroke.
    JAMA Neurol. 2024;81:1102-1103.
    PubMed    
    
    
    September 2024
35. LI J, Shlobin NA, Thijs RD, Sylvestre MP, et al
    Antiseizure Medications and Cardiovascular Events in Older People With Epilepsy.
    JAMA Neurol. 2024 Sep 30. doi: 10.1001/jamaneurol.2024.3210.
    PubMed     Abstract available
    
    
    
36. MAARSE M, Seiffge DJ, Werring DJ, Boersma LVA, et al
    Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation.
    JAMA Neurol. 2024 Sep 23:e242882. doi: 10.1001/jamaneurol.2024.2882.
    PubMed     Abstract available
    
    
    August 2024
37. LI R, Tao C, Sun J, Zhang C, et al
    Endovascular vs Medical Management of Acute Basilar Artery Occlusion: A Secondary Analysis of a Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 26:e242652. doi: 10.1001/jamaneurol.2024.2652.
    PubMed     Abstract available
    
    
    
38. RENEDO D, Sheth KN
    Sex Differences in Case-Fatality Rates of Stroke-Reply.
    JAMA Neurol. 2024 Aug 19. doi: 10.1001/jamaneurol.2024.2599.
    PubMed    
    
    
    
39. WESSELS L, Wolf S, Adage T, Breitenbach J, et al
    Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 19:e242564. doi: 10.1001/jamaneurol.2024.2564.
    PubMed     Abstract available
    
    
    
40. NAVI BB, Zhang C, Miller B, Cushman M, et al
    Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial.
    JAMA Neurol. 2024 Aug 12:e242404. doi: 10.1001/jamaneurol.2024.2404.
    PubMed     Abstract available
    
    
    
41. CHEN H, Lee JS, Michel P, Yan B, et al
    Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core: A Review.
    JAMA Neurol. 2024 Aug 12. doi: 10.1001/jamaneurol.2024.2500.
    PubMed     Abstract available
    
    
    July 2024
42. HADAD R, Mandelli ML, Rankin KP, Toohey C, et al
    Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration.
    JAMA Neurol. 2024 Jul 22:e242213. doi: 10.1001/jamaneurol.2024.2213.
    PubMed     Abstract available
    
    
    
43. ASKEN BM, Scholz SW, Prokop S
    Substantia(l) Impacts of Contact Sport Play and Parkinsonism.
    JAMA Neurol. 2024 Jul 15. doi: 10.1001/jamaneurol.2024.2162.
    PubMed    
    
    
    
44. COLUMBO JA, Daya N, Colantonio LD, Wang Z, et al
    Derivation and Validation of ICD-10 Codes for Identifying Incident Stroke.
    JAMA Neurol. 2024 Jul 1:e242044. doi: 10.1001/jamaneurol.2024.2044.
    PubMed     Abstract available
    
    
    
45. PRABHAKARAN S, Romano JG
    Symptomatic Hemorrhage Risks in Stroke Thrombolysis: aDAPTing to Real-World Practice.
    JAMA Neurol. 2024;81:689-691.
    PubMed    
    
    
    June 2024
46. HINDSHOLM MF, Garcia Rodriguez LA, Brandes A, Hallas J, et al
    Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants.
    JAMA Neurol. 2024 Jun 24:e241892. doi: 10.1001/jamaneurol.2024.1892.
    PubMed     Abstract available
    
    
    
47. BAX F, Greenberg SM
    Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage.
    JAMA Neurol. 2024 Jun 10. doi: 10.1001/jamaneurol.2024.1595.
    PubMed    
    
    
    
48. SEITZ A, Merkler AE
    Time to Think About Myocardial Infarction in Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3. doi: 10.1001/jamaneurol.2024.1547.
    PubMed    
    
    
    
49. JOUNDI RA, Smith EE, Ganesh A, Nogueira RG, et al
    Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3:e241562. doi: 10.1001/jamaneurol.2024.1562.
    PubMed     Abstract available
    
    
    
50. NOLTE CH, von Rennenberg R, Litmeier S, Leistner DM, et al
    Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.
    JAMA Neurol. 2024 Jun 3:e241552. doi: 10.1001/jamaneurol.2024.1552.
    PubMed     Abstract available
    
    
    May 2024
51. GAO Y, Jiang L, Pan Y, Chen W, et al
    Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial.
    JAMA Neurol. 2024 May 28:e241433. doi: 10.1001/jamaneurol.2024.1433.
    PubMed     Abstract available
    
    
    
52. GOELDLIN MB, Hakim A, Branca M, Abend S, et al
    Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
    JAMA Neurol. 2024 May 28:e241450. doi: 10.1001/jamaneurol.2024.1450.
    PubMed     Abstract available
    
    
    
53. LI Y, Ren T, Burgess M, Chen Z, et al
    Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance.
    JAMA Neurol. 2024 May 23:e241187. doi: 10.1001/jamaneurol.2024.1187.
    PubMed     Abstract available
    
    
    
54. PENG TJ, Schwamm LH, Fonarow GC, Hassan AE, et al
    Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis.
    JAMA Neurol. 2024 May 20:e241312. doi: 10.1001/jamaneurol.2024.1312.
    PubMed     Abstract available
    
    
    
55. KAUFMANN JE, Harshfield EL, Gensicke H, Wegener S, et al
    Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis.
    JAMA Neurol. 2024 May 13:e241141. doi: 10.1001/jamaneurol.2024.1141.
    PubMed     Abstract available
    
    
    April 2024
56. ZHAO W, Li S, Li C, Wu C, et al
    Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Apr 22:e240868. doi: 10.1001/jamaneurol.2024.0868.
    PubMed     Abstract available
    
    
    
57. KOURI N, Frankenhauser I, Peng Z, Labuzan SA, et al
    Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    JAMA Neurol. 2024 Apr 15:e240784. doi: 10.1001/jamaneurol.2024.0784.
    PubMed     Abstract available
    
    
    
58. PEASE M, Mittal A, Merkaj S, Okonkwo DO, et al
    Early Seizure Prophylaxis in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2024 Apr 8:e240689. doi: 10.1001/jamaneurol.2024.0689.
    PubMed     Abstract available
    
    
    
59. HABIB S, Butt H, Goldenholz SR, Chang CY, et al
    Large Language Model Performance on Practice Epilepsy Board Examinations.
    JAMA Neurol. 2024 Apr 8:e240676. doi: 10.1001/jamaneurol.2024.0676.
    PubMed    
    
    
    
60. SPOTNITZ M, Ekanayake CD, Ostropolets A, McKhann GM, et al
    Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy.
    JAMA Neurol. 2024 Apr 1:e240551. doi: 10.1001/jamaneurol.2024.0551.
    PubMed     Abstract available
    
    
    March 2024
61. DECARLI C, Maillard P, Pase MP, Beiser AS, et al
    Trends in Intracranial and Cerebral Volumes of Framingham Heart Study Participants Born 1930 to 1970.
    JAMA Neurol. 2024 Mar 25:e240469. doi: 10.1001/jamaneurol.2024.0469.
    PubMed     Abstract available
    
    
    
62. CHEN HS, Cui Y, Wang XH, Ma YT, et al
    Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial.
    JAMA Neurol. 2024 Mar 11:e240146. doi: 10.1001/jamaneurol.2024.0146.
    PubMed     Abstract available
    
    
    
63. CHENG A, Xue J, Wang A, Xu Q, et al
    LDL-C Levels and Bleeding Risk in Patients Taking DAPT After Minor Ischemic Stroke or TIA.
    JAMA Neurol. 2024 Mar 4:e240086. doi: 10.1001/jamaneurol.2024.0086.
    PubMed     Abstract available
    
    
    
64. RENEDO D, Acosta JN, Leasure AC, Sharma R, et al
    Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019.
    JAMA Neurol. 2024 Mar 4:e240190. doi: 10.1001/jamaneurol.2024.0190.
    PubMed     Abstract available
    
    
    February 2024
65. WON SY, Hernandez-Duran S, Behmanesh B, Bernstock JD, et al
    Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts.
    JAMA Neurol. 2024 Feb 26:e235773. doi: 10.1001/jamaneurol.2023.5773.
    PubMed     Abstract available
    
    
    
66. SCHNEIDER ALC, Law CA, Gottesman RF, Krauss G, et al
    Posttraumatic Epilepsy and Dementia Risk.
    JAMA Neurol. 2024 Feb 26:e240010. doi: 10.1001/jamaneurol.2024.0010.
    PubMed     Abstract available
    
    
    
67. ANDERSON CS, Song L
    Promising Efforts to Define a Novel Approach to Neuroprotection for Acute Ischemic Stroke.
    JAMA Neurol. 2024 Feb 19. doi: 10.1001/jamaneurol.2023.5727.
    PubMed    
    
    
    
68. FU Y, Wang A, Tang R, Li S, et al
    Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial.
    JAMA Neurol. 2024 Feb 19:e235716. doi: 10.1001/jamaneurol.2023.5716.
    PubMed     Abstract available
    
    
    
69. MUTLU U, Fokkink WJR, van Kooten F
    Shifting Carotid Web Due to a Wandering and Rotating Carotid Artery.
    JAMA Neurol. 2024 Feb 12. doi: 10.1001/jamaneurol.2023.5641.
    PubMed    
    
    
    
70. SHETH KN, Solomon N, Alhanti B, Messe SR, et al
    Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage.
    JAMA Neurol. 2024 Feb 9. doi: 10.1001/jamaneurol.2024.0221.
    PubMed     Abstract available
    
    
    
71. SARRAJ A, Hill MD, Hussain MS, Abraham MG, et al
    Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial.
    JAMA Neurol. 2024 Feb 8. doi: 10.1001/jamaneurol.2024.0206.
    PubMed     Abstract available
    
    
    
72. MEINEL TR, Wardlaw JM, Kent DM
    Is Incidentally Discovered Covert Cerebrovascular Disease Ignorable?
    JAMA Neurol. 2024 Feb 5. doi: 10.1001/jamaneurol.2023.5456.
    PubMed    
    
    
    
73. PETERSEN CL, Hougaard A, Gaist D, Hallas J, et al
    Risk of Stroke and Myocardial Infarction Among Initiators of Triptans.
    JAMA Neurol. 2024 Feb 5. doi: 10.1001/jamaneurol.2023.5549.
    PubMed     Abstract available
    
    
    
74. CUCCHIARA B, Majersik JJ
    The Case of Anticoagulation for Progressing Stroke: Have We Come Full Circle?
    JAMA Neurol. 2024;81:113-114.
    PubMed    
    
    
    January 2024
75. DE HAVENON A, Zhou LW, Koo AB, Matouk C, et al
    Endovascular Treatment of Acute Ischemic Stroke After Cardiac Interventions in the United States.
    JAMA Neurol. 2024 Jan 29. doi: 10.1001/jamaneurol.2023.5416.
    PubMed     Abstract available
    
    
    
76. HOUKIN K, Osanai T, Uchiyama S, Minematsu K, et al
    Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 16:e235200. doi: 10.1001/jamaneurol.2023.5200.
    PubMed     Abstract available
    
    
    
77. ZHANG X, Zhong W, Xue R, Jin H, et al
    Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 8:e235093. doi: 10.1001/jamaneurol.2023.5093.
    PubMed     Abstract available
    
    
    
78. NOGUEIRA RG, Lobsien D, Klisch J, Pielenz D, et al
    Thrombectomy With the pRESET vs Solitaire Stent Retrievers as First-Line Large Vessel Occlusion Stroke Treatment: A Randomized Clinical Trial.
    JAMA Neurol. 2024 Jan 2:e235010. doi: 10.1001/jamaneurol.2023.5010.
    PubMed     Abstract available
    
    
    December 2023
79. RIVIER CA, Kamel H, Sheth KN, Iadecola C, et al
    Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage.
    JAMA Neurol. 2023 Dec 26:e234918. doi: 10.1001/jamaneurol.2023.4918.
    PubMed     Abstract available
    
    
    
80. HENDRIKS S, Ranson JM, Peetoom K, Lourida I, et al
    Risk Factors for Young-Onset Dementia in the UK Biobank.
    JAMA Neurol. 2023 Dec 26:e234929. doi: 10.1001/jamaneurol.2023.4929.
    PubMed     Abstract available
    
    
    
81. BUCK BH, Sposato LA, Field TS
    Looking for Atrial Fibrillation With Insertable Cardiac Monitors-Is 1 Year Long Enough and Does it Matter?
    JAMA Neurol. 2023;80:1266-1268.
    PubMed    
    
    
    
82. BRAKSICK SA, Rabinstein AA
    Antiplatelets Are Enough for Nondisabling Strokes.
    JAMA Neurol. 2023;80:1263-1264.
    PubMed    
    
    
    November 2023
83. IAFFALDANO P, Portaccio E, Lucisano G, Simone M, et al
    Multiple Sclerosis Progression and Relapse Activity in Children.
    JAMA Neurol. 2023 Nov 27:e234455. doi: 10.1001/jamaneurol.2023.4455.
    PubMed     Abstract available
    
    
    
84. HUA L, Zhao Y, Han YS
    A Young Woman With Hypertonia, Severe Scoliosis, and Encephalopathy.
    JAMA Neurol. 2023 Nov 27. doi: 10.1001/jamaneurol.2023.4245.
    PubMed    
    
    
    
85. SUN D, Guo X, Nguyen TN, Pan Y, et al
    Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct: A Secondary Analysis of the ANGEL-ASPECT Trial.
    JAMA Neurol. 2023 Nov 27:e234430. doi: 10.1001/jamaneurol.2023.4430.
    PubMed     Abstract available
    
    
    
86. COHEN MJ, Meador KJ, Loring DW, Matthews AG, et al
    Behavioral Outcomes and Neurodevelopmental Disorders Among Children of Women With Epilepsy.
    JAMA Neurol. 2023 Nov 20:e234315. doi: 10.1001/jamaneurol.2023.4315.
    PubMed     Abstract available
    
    
    
87. STEWARD A, Biel D, Dewenter A, Roemer S, et al
    ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
    JAMA Neurol. 2023 Nov 6:e234038. doi: 10.1001/jamaneurol.2023.4038.
    PubMed     Abstract available
    
    
    
88. ABDELHAK A, Benkert P, Schaedelin S, Boscardin WJ, et al
    Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
    JAMA Neurol. 2023 Nov 6:e233997. doi: 10.1001/jamaneurol.2023.3997.
    PubMed     Abstract available
    
    
    
89. ZACHRISON KS, Beaulieu ND, Mehrotra A
    Changing Health Care Markets Have the Potential to Undermine Stroke Systems of Care.
    JAMA Neurol. 2023;80:1131-1132.
    PubMed    
    
    
    October 2023
90. BERNSTEIN RA, Kamel H, Granger CB, Piccini JP, et al
    Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial.
    JAMA Neurol. 2023 Oct 30:e233931. doi: 10.1001/jamaneurol.2023.3931.
    PubMed     Abstract available
    
    
    
91. SMITH AG, Singleton JR, Aperghis A, Coffey CS, et al
    Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
    JAMA Neurol. 2023 Oct 23:e233711. doi: 10.1001/jamaneurol.2023.3711.
    PubMed     Abstract available
    
    
    
92. LAVALLEE PC, Charles H, Albers GW, Caplan LR, et al
    Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events.
    JAMA Neurol. 2023 Oct 2:e233344. doi: 10.1001/jamaneurol.2023.3344.
    PubMed     Abstract available
    
    
    September 2023
93. MARTINEZ-GUTIERREZ JC, Kim Y, Salazar-Marioni S, Tariq MB, et al
    Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial.
    JAMA Neurol. 2023 Sep 18:e233206. doi: 10.1001/jamaneurol.2023.3206.
    PubMed     Abstract available
    
    
    
94. MISRA S, Kasner SE, Dawson J, Tanaka T, et al
    Outcomes in Patients With Poststroke Seizures: A Systematic Review and Meta-Analysis.
    JAMA Neurol. 2023 Sep 18:e233240. doi: 10.1001/jamaneurol.2023.3240.
    PubMed     Abstract available
    
    
    
95. ELSER H, Vijayaraghavan M, Kasner SE
    E-Cigarettes and Stroke Risk-Present Uncertainties and Future Directions.
    JAMA Neurol. 2023;80:883-884.
    PubMed    
    
    
    August 2023
96. MCKEE AC, Mez J, Abdolmohammadi B, Butler M, et al
    Neuropathologic and Clinical Findings in Young Contact Sport Athletes Exposed to Repetitive Head Impacts.
    JAMA Neurol. 2023 Aug 28:e232907. doi: 10.1001/jamaneurol.2023.2907.
    PubMed     Abstract available
    
    
    
97. WECHSLER PM, Navi BB
    Bypassing Closest Stroke Center for Intracerebral Hemorrhage-Not So Fast!
    JAMA Neurol. 2023 Aug 21. doi: 10.1001/jamaneurol.2023.2753.
    PubMed    
    
    
    
98. RAMOS-PACHON A, Rodriguez-Luna D, Marti-Fabregas J, Millan M, et al
    Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage: A Secondary Analysis of the RACECAT Randomized Clinical Trial.
    JAMA Neurol. 2023 Aug 21:e232754. doi: 10.1001/jamaneurol.2023.2754.
    PubMed     Abstract available
    
    
    
99. HAUSER RA, Espay AJ, Ellenbogen AL, Fernandez HH, et al
    IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial.
    JAMA Neurol. 2023 Aug 14:e232679. doi: 10.1001/jamaneurol.2023.2679.
    PubMed     Abstract available
    
    
    
100. WOLF S, Mielke D, Barner C, Malinova V, et al
     Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial.
     JAMA Neurol. 2023;80:833-842.
     PubMed     Abstract available
     
     
     July 2023
101. CHALOS V, Venema E, Mulder MJHL, Roozenbeek B, et al
     Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.
     JAMA Neurol. 2023 Jul 31:e232392. doi: 10.1001/jamaneurol.2023.2392.
     PubMed     Abstract available
     
     
     
102. BHATIA KD, Chowdhury S, Andrews I, Goetti R, et al
     Association Between Thrombectomy and Functional Outcomes in Pediatric Patients With Acute Ischemic Stroke From Large Vessel Occlusion.
     JAMA Neurol. 2023 Jul 24:e232303. doi: 10.1001/jamaneurol.2023.2303.
     PubMed     Abstract available
     
     
     
103. BALA F, Singh N, Buck B, Ademola A, et al
     Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
     JAMA Neurol. 2023 Jul 10:e232094. doi: 10.1001/jamaneurol.2023.2094.
     PubMed     Abstract available
     
     
     
104. SCHAPER FLWVJ, Nordberg J, Cohen AL, Lin C, et al
     Mapping Lesion-Related Epilepsy to a Human Brain Network.
     JAMA Neurol. 2023 Jul 3:e231988. doi: 10.1001/jamaneurol.2023.1988.
     PubMed     Abstract available
     
     
     June 2023
105. WANG A, Jia B, Zhang X, Huo X, et al
     Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
     JAMA Neurol. 2023 Jun 26:e231871. doi: 10.1001/jamaneurol.2023.1871.
     PubMed     Abstract available
     
     
     
106. HERNANDEZ-JIMENEZ M, Abad-Santos F, Cotgreave I, Gallego J, et al
     Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.
     JAMA Neurol. 2023 Jun 20:e231660. doi: 10.1001/jamaneurol.2023.1660.
     PubMed     Abstract available
     
     
     
107. ANDRES W, Rothstein A, Elser H, Sloane KL, et al
     Trends in the Prevalence of Stroke Among Community-Dwelling Individuals in the US, 1999-2018.
     JAMA Neurol. 2023;80:646-648.
     PubMed    
     
     
     May 2023
108. WARACH SJ, Ranta A, Kim J, Song SS, et al
     Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
     JAMA Neurol. 2023 May 30:e231449. doi: 10.1001/jamaneurol.2023.1449.
     PubMed     Abstract available
     
     
     
109. WARDLAW JM, Woodhouse LJ, Mhlanga II, Oatey K, et al
     Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial.
     JAMA Neurol. 2023 May 24:e231526. doi: 10.1001/jamaneurol.2023.1526.
     PubMed     Abstract available
     
     
     
110. VAN DER ENDE NAM, Roozenbeek B, Smagge LEM, Luijten SPR, et al
     Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
     JAMA Neurol. 2023 May 22:e231262. doi: 10.1001/jamaneurol.2023.1262.
     PubMed     Abstract available
     
     
     
111. HITTLE M, Culpepper WJ, Langer-Gould A, Marrie RA, et al
     Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region.
     JAMA Neurol. 2023 May 15:e231135. doi: 10.1001/jamaneurol.2023.1135.
     PubMed     Abstract available
     
     
     
112. KHOSHKHOO S, Wang Y, Chahine Y, Erson-Omay EZ, et al
     Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy.
     JAMA Neurol. 2023 May 1:e230473. doi: 10.1001/jamaneurol.2023.0473.
     PubMed     Abstract available
     
     
     
113. CHATURVEDI S
     Transcarotid Artery Revascularization for Stroke Prevention-Multiple Elephants in the Room.
     JAMA Neurol. 2023;80:435-436.
     PubMed    
     
     
     
114. CHAKRABORTY AP, Mukherjee A, Biswas A
     Limb to Cranial Overflow Dystonia in a Patient After Stroke.
     JAMA Neurol. 2023;80:529.
     PubMed    
     
     
     April 2023
115. MCENTIRE CRS, Fletcher A, Toledano M, Epstein S, et al
     Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression.
     JAMA Neurol. 2023 Apr 24:e230841. doi: 10.1001/jamaneurol.2023.0841.
     PubMed     Abstract available
     
     
     
116. SINKA L, Abraira L, Imbach LL, Zieglgansberger D, et al
     Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model.
     JAMA Neurol. 2023 Apr 10:e230611. doi: 10.1001/jamaneurol.2023.0611.
     PubMed     Abstract available
     
     
     
117. CHABANNE R, Geeraerts T, Begard M, Balanca B, et al
     Outcomes After Endovascular Therapy With Procedural Sedation vs General Anesthesia in Patients With Acute Ischemic Stroke: The AMETIS Randomized Clinical Trial.
     JAMA Neurol. 2023 Apr 3:e230413. doi: 10.1001/jamaneurol.2023.0413.
     PubMed     Abstract available
     
     
     March 2023
118. TAI XY, Torzillo E, Lyall DM, Manohar S, et al
     Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors.
     JAMA Neurol. 2023 Mar 27:e230339. doi: 10.1001/jamaneurol.2023.0339.
     PubMed     Abstract available
     
     
     
119. SENERS P, Yuen N, Mlynash M, Snyder SJ, et al
     Quantification of Penumbral Volume in Association With Time From Stroke Onset in Acute Ischemic Stroke With Large Vessel Occlusion.
     JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0265.
     PubMed     Abstract available
     
     
     
120. HSU CY, Saver JL, Ovbiagele B, Wu YL, et al
     Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and Meta-Regression.
     JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0218.
     PubMed     Abstract available
     
     
     
121. LIANG P, Cronenwett JL, Secemsky EA, Eldrup-Jorgensen J, et al
     Risk of Stroke, Death, and Myocardial Infarction Following Transcarotid Artery Revascularization vs Carotid Endarterectomy in Patients With Standard Surgical Risk.
     JAMA Neurol. 2023 Mar 20. doi: 10.1001/jamaneurol.2023.0285.
     PubMed     Abstract available
     
     
     
122. ZEDDE M, Moratti C, Pascarella R
     Multimodal Neuroimaging of Intimal Flap in a Basilar Artery Dissection.
     JAMA Neurol. 2023 Mar 13. doi: 10.1001/jamaneurol.2023.0126.
     PubMed    
     
     
     
123. MISTRY EA
     Building Evidence on Safety of Thrombolysis for Patients Undergoing Direct Oral Anticoagulant Treatment.
     JAMA Neurol. 2023;80:231-232.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.